Reducing Fill Risk in Drug Product Manufacture Utilizing New State-of-the-Art Systems and Platforms

Cell Culture Dish Podcast

Content provided by Brandy Sargent. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brandy Sargent or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4y ago 17:49

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on October 08, 2023 10:07 (12M ago). Last successful fetch was on May 24, 2023 15:24 (1+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this podcast we talked with DQ Wang, PhD, and Vice President, Formulation, Fill and Finish of WuXi Biologics about their DP4 multi-product fill & finish facility featuring the Vanrx SA25 robotic, gloveless, isolator-based filling system. The system significantly reduces drug product fill risk and provides greater aseptic assurance.

76 episodes

#Science #Life Sciences #Biology #Natural Sciences #Fitness #Medicine #Brandy Sargent